Silver Book

Silver Book Fact

A study looking at the effects of cardiovascular medicines in elderly patients who had previous heart attacks, found a total death rate reduction of 24% between 1995 and 2004.

Setoguchi S, Glynn R, Avorn J, Mittleman M, et al. Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-year trend analysis. JACC. 2008; 51(13): 1247-54. http://content.onlinejacc.org/cgi/content/abstract/51/13/1247?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Setoguchi&fulltext=Improvements+in+long-term+mortality&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HW

Reference

Title
Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-year trend analysis
Publication
JACC
Publication Date
2008
Authors
Setoguchi S, Glynn R, Avorn J, Mittleman M, et al
Volume & Issue
Volume 51, Issue 13
Pages
1247-54
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Survival Rates of SAS Patients with and without SAVR
    Patients with severe aortic stenosis (SAS) ages 80+ who underwent surgical aortic valve replacement (SAVR) have 1-year, 2-year, and 5-year survival rates of 87%, 78%, and 68% respectively — compared with…  
  • Effectiveness of treating ischemic strokert-PA within 3 hours of symptom onset
    A study of the  victims with effectiveness of treating ischemic strokert-PA within 3 hours of symptom onset showed a decrease in rehabilitation costs of $1.4 million and nursing home costs of…  
  • The development of antioxidants that reduce oxidative damage is underway. One antioxidant that has been found, uric acid, has an even greater protective effect when combined with tPA.  
  • TAVR Success in sSAS Patients
    A study of severe symptomatic aortic stenosis (sSAS) patients who received transcatheter aortic valve replacement (TAVR) found 30-day mortality of 2.2% for those who were high risk of surgical mortality/inoperable,…  
  • Increased use of a blood-thinning drug saves $600 million annually, because of the strokes it prevents.